Hall, W, Degenhardt, L. Cannabis use and psychosis: a review of clinical and epidemiological evidence. Aust N Z J Psychiatry
2000; 34: 26–34.
D'Souza, DC, Abi-Saab, WM, Madonick, S, Forselius-Bielen, K, Doersch, A, Braley, G, Gueorguieva, R, Cooper, TB, Krystal, JH. Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biol Psychiatry
2005; 57: 594–608.
D'Souza, DC, Perry, E, MacDougall, L, Ammerman, Y, Cooper, T, Wu, YT, Braley, G, Gueorguieva, R, Krystal, JH. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacol
2004; 29: 1558–72.
Thomas, H. A community survey of adverse effects of cannabis use. Drug Alcohol Depend
1996; 42: 201–7.
Moore, TH, Zammit, S, Lingford-Hughes, A, Barnes, TR, Jones, PB, Burke, M, Lwis, G. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet
2007; 370: 319–28.
Dixon, L, Haas, G, Weiden, P, Sweeney, J, Frances, A. Acute effects of drug abuse in schizophrenic patients: Clinical observations and patients' selfreports. Schizophr Bull
1990; 16: 69–79.
Schofield, D, Tennant, C, Nash, L, Degenhardt, L, Cornish, A, Hobbs, C, Brennan, G. Reasons for cannabis use in psychosis. Aust N Z J Psychiatry
2006; 40: 570–4.
Ferdinand, RF, Sondeijker, F, van der Ende, J, Selten, JP, Huizink, A, Verhulst, FC. Cannabis use predicts future psychotic symptoms, and vice versa. Addiction
2005; 100: 612–8.
Hides, L, Dawe, S, Kavanagh, DJ, Young McD, R. A prospective study of psychotic symptom and cannabis relapse in recent onset psychosis. Br J Psychiatry
2006; 189: 137–43.
Stroup, DF, Berlin, JA, Morton, SC, Olkin, I, Williamson, GD, Rennie, D, Moher, D, Becker, BJ, Sipe, TA, Thacker, SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA
2000; 283: 2008–12.
Wade, D, Harrigan, S, Edwards, J, Burgess, PM, Whelan, G, McGorry, PD. Substance misuse in first-episode psychosis: 15-month prospective follow-up study. Br J Psychiatry
2006; 189: 229–34.
Pencer, A, Addington, J, Addington, D. Outcome of a first episode of psychosis in adolescence: a 2-year follow-up. Psychiatry Res
2005; 133: 35–43.
Coldham, EL, Addington, J, Addington, D. Medication adherence of individuals with a first episode of psychosis. Acta Psychiatr Scand
2002; 106: 286–90.
Grech, A, van Os, J, Jones, PB, Lewis, SW, Murray, RM. Cannabis use and outcome of recent onset psychosis. Eur Psychiatry; 20: 349–53.
Stirling, J, Lewis, S, Hopkins, R, White, C. Cannabis use prior to first onset psychosis predicts spared neurocognition at 10-year follow-up. Schizophr Res
2005; 75: 135–7.
Green, AI, Tohen, MF, Hamer, RM, Strakowski, SM, Lieberman, JA, Glick, I, Clark, WS; HGDH Research Group. First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol. Schizophr Res
2004; 66: 125–35.
Martinez-Arevalo, MJ, Calcedo-Ordonez, A, Varo-Prieto, JR. Cannabis consumption as a prognostic factor in schizophrenia. Br J Psychiatry
1994; 164: 679–81.
Arango, C, Calcedo, BA, Gonzalez, S, Calcedo, OA. Violence in inpatients with schizophrenia: a prospective study. Schizophr Bull
1999; 25: 493–503.
Arias Horcajadas, F, Romero, SS, Calo, JJP. Relevance of drug use in clinical manifestations of schizophrenia [Spanish]. Actas Esp Psiquiatr
2002; 30: 65–73.
Caspari, D. Cannabis and schizophrenia: results of a follow-up study. Eur Arch Psychiatry Clin Neurosci
1999; 249: 45–9.
Degenhardt, L, Tennant, C, Gilmour, S, Schofield, D, Nash, L, Hall, W, McKay, D. The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study. Psychol Med
2007; 37: 1–8.
Grace, RF, Shenfield, G, Tennant, C. Cannabis and psychosis in acute psychiatric admissions. Drug Alcohol Rev
2000; 19: 287–90.
Addington, J, Addington, D. Patterns, predictors and impact of substance use in early psychosis: a longitudinal study. Acta Psychiatr Scand
2007; 115: 304–9.
Arseneault, L, Moffitt, TE, Caspi, A, Taylor, PJ, Silva, PA. Mental disorders and violence in a total birth cohort: results from the Dunedin Study. Arch Gen Psychiatry
2000; 57: 979–86.
Linszen, DH, Dingemans, PM, Lenior, ME. Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry
1994; 51: 273–9.
Linszen, DH, Dingemans, PM, Nugter, MA, Van der Does, AJ, Scholte, WF, Lenior, MA. Patient attributes and expressed emotion as risk factors for psychotic relapse. Schizophr Bull
1997; 23: 119–30.
Pencer, A, Addington, J. Substance use and cognition in early psychosis. J Psychiatry Neurosci
2003; 28: 48–54.
Lauronen, E, Miettunen, J, Veijola, J, Karhu, M, Jones, PB, Isohanni, M. Outcome and its predictors in schizophrenia within the Northern Finland 1966 Birth Cohort. Eur Psychiatry
2007; 22: 129–36.
Munk-Jorgensen, P, Mortensen, PB. Social outcome in schizophrenia: a 13-year follow-up. Soc Psychiatry Psychiatr Epidemiol
1992; 27: 129–34.
Hofler, M, Lieb, R, Perkonigg, A, Schuster, P, Sonntag, H, Wittchen, HU. Covariates of cannabis use progression in a representative population sample of adolescents: a prospective examination of vulnerability and risk factors. Addiction
1999; 94: 1679–94.
von Sydow, K, Lieb, R, Pfister, H, Hofler, M, Wittchen, HU. What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults. Drug Alcohol Depend
2002; 68: 49–64.
Jane-Llopis, E, Matytsina, I. Mental health and alcohol, drugs and tobacco: a review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs. Drug Alcohol Rev
2006; 25: 515–36.
Regier, DA, Farmer, ME, Rae, DS, Locke, BZ, Keith, SJ, Judd, LL, Goodwin, FK. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA
1990; 264: 2511–8.
Mueser, KT, Yarnold, PR, Bellack, AS. Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder. Acta Psychiatr Scand
1992; 85: 48–55.